Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
REGENXBIO
Biotech
Adverum's gene therapy reduces treatment burden in wet AMD
Adverum’s ixo-vec, a gene therapy for wet AMD, has demonstrated a reduction in treatment burden and maintained visual acuity in a phase 2 study.
Gabrielle Masson
Feb 8, 2024 11:17am
Regenxbio-AbbVie in-office gene therapy clears phase 2 test
Jan 17, 2024 9:42am
SQZ lays off 80% of staff, Regenxbio cuts 15%
Nov 9, 2023 8:23am
Chasing Pfizer, Regenxbio benefits from FDA boost in DMD
Apr 11, 2023 9:45am
RegenXBio gets FDA support for accelerated gene therapy filing
Aug 3, 2022 10:00am